Certified by Founder Lodge
Carmot Therapeutics, Inc.
United States - Berkeley
START UP
1 Disclosed Funding Rounds $160,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Ch
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 26 ,2022 | Series D | $160,000,000 | |
| May, 31 ,2023 | Series E | $150,000,000.00 |
Horizons Ventures
The Column Group
RA Capital Management, L.P.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
